Losan Pharma and FabRx have demonstrated the potential of selective laser sintering 3D printing to fabricate orodispersible printlets with characteristics similar to a commercial orally disintegrating tablet, but with the added benefit of using a manufacturing technology able to prepare medicines individualized to the patient.

The study was published in Pharmaceutics 2020, 12, 110.

> View publication